I personally dont have an opinion on the newbies......but I thing holders should actually read and digest the Jorc table in the ann.....the evidence is pretty flimsy for the spend Imo.
GPP should have done their own sample programme and the deal subject to those assays being positive.
The way this deal has been done shareholders face all the risk. DB
Ann: Invalid Section 249D Notice, page-127
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
